CNBC's Andrew Ross Sorkin reports on the latest news.
Breakdown
- AbbVie agrees to lower drug prices for three years with White House 2s
- Deal includes a tariff exemption for AbbVie 7s
- AbbVie pledges $100 billion for U.S. research and development 13s
- Similar deals were made in December with Merck, Roche, and Gilead 30s
- Agreement is part of broader efforts to improve drug affordability 41s